Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs
08 avr. 2020 07h30 HE
|
Pacific Biosciences of California, Inc.
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2...
MOgene Selects Fluidigm Advanta Assays and Juno System to Expand Its NGS Services Portfolio
13 janv. 2020 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM)...
Next Generation Sequencing (NGS) Services Market Worth $13.1 Billion by 2025- Exclusive Report by Meticulous Research®
10 oct. 2019 10h14 HE
|
Meticulous Market Research Pvt. Ltd.
London, Oct. 10, 2019 (GLOBE NEWSWIRE) -- According to a new market research report “Next Generation Sequencing (NGS) Services Market by Service Type (Targeted Sequencing, Exome, RNA-Seq, ChIP...
Cofactor Genomics Launches ImmunoPrism™ Immune Profiling Kit, for Use in Clinical Sequencing Laboratories
30 oct. 2018 08h00 HE
|
Cofactor Genomics
--Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions-- SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cofactor...
Global Next Generation Sequencing (NGS) Market to Grow Significantly from USD 4.93 billion in 2017 to USD 17.44 billion in 2024, at a CAGR of 22.2% from 2018 to 2024
29 oct. 2018 06h58 HE
|
Energias Market Research
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Global Next Generation Sequencing (NGS) market is expected to grow significantly from USD 4.93 billion in 2017 to USD 17.44 billion in 2024, at a CAGR of...
Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM
02 oct. 2018 08h00 HE
|
Cofactor Genomics
CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions SAN FRANCISCO, Oct. 02, 2018 (GLOBE...
ABclonal Technology Unveils Next-Generation Sequencing Kits for Illumina Sequencing Platforms
13 sept. 2018 10h00 HE
|
ABclonal Technology
BOSTON, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ABclonal Technology, a dynamic and growing provider of biological reagents for life science research, today unveiled its new line of next-generation...
Cofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assay
20 mars 2018 08h30 HE
|
Cofactor Genomics
SAN FRANCISCO, March 20, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National...
Cofactor Genomics Launches Paragon, a Comprehensive Quantitative Solid Tumor Immune Profiling Assay
08 févr. 2018 08h00 HE
|
Cofactor Genomics
SAN FRANCISCO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the commercial launch of Paragon, a solid tumor...